血清性囊瘤:对诊断和管理的审查
Kylie Ning1, Ashley Salamone1, Lindsey Manos2
1Division of Gastroenterology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Journal of clinical medicine
|December 9, 2023
概括
血清性囊瘤 (SCAs) 是常见的良性胰腺囊. 在手术前区分SCA和癌对于适当的管理和避免不必要的随访至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
背景情况:
- 偶然的胰腺囊是常见的,需要基于恶性瘤风险的管理.
- 血清性囊瘤 (SCAs) 是最常见的良性胰腺囊.
- SCAs可以呈现非典型的成像特征,模仿恶性病变.
研究的目的:
- 审查目前关于血清性细胞瘤的诊断和管理的证据.
- 为了强调手术前区分SCAs和其他胰腺囊的重要性.
- 为了应对在成像上区分SCAs的挑战.
主要方法:
- 对SCAs的诊断和管理策略的文献综述.
- 对成像特征的分析,使SCAs与其他囊性瘤有所区别.
- 目前用于SCA管理的临床指南的摘要.
主要成果:
- SCAs通常表现出特征性成像模式,但可以具有非典型的呈现.
- 精确的SCA手术前诊断可以避免进一步监测的需要.
- 对SCAs的错误诊断可能导致不适当的患者管理和潜在的伤害.
结论:
- 术前对SCAs与恶性或癌前囊的区分至关重要.
- 提高SCA的诊断准确度可以优化患者护理途径.
- 本综述提供了SCA诊断和管理的全面概述.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
92
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
92
Appendicitis-II: Diagnostic Studies and Management
80
Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
80
Cystic Fibrosis: Management
170
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
170


